In contrast, Liu et al. reported that full-length ADAMTS1 increased the number of lung metastases while C-terminal regions of the protein exhibited anti-metastatic activity using two tumor models—TA3 mammary carcinoma and Lewis lung carcinoma [66]. Here, ADAMTS1 is linked to neoplasm.